Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FDFT1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA527995
Description
Recommended positive controls: 293T, A431. Predicted reactivity: Mouse (90%), Rat (88%), Pig (93%), Rhesus Monkey (99%), Chimpanzee (100%), Bovine (92%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
FDFT1 catalyzes the first step in the cholesterol biosynthetic pathway, the conversion of trans-farnesyldiphosphate to squalene. The loss of promoter activity and response to sterols for FDFT1 is localized to a 69-bp section positioned 131 bp 5-prime to the transcription start site. Sequence analysis of this region shows that it contains a sterol regulatory element-1 (SRE1) previously identified in other sterol regulated genes and 2 putative NF1 binding sites.
Specifications
| FDFT1 | |
| Polyclonal | |
| Unconjugated | |
| FDFT1 | |
| DGPT; EGK_18680; ERG9; farnesyl diphosphate farnesyl transferase 1; farnesyl diphosphate farnesyltransferase; farnesyl-diphosphate farnesyltransferase; farnesyl-diphosphate farnesyltransferase 1; FDFT1; FPP:FPP farnesyltransferase; presqualene-di-diphosphate synthase; SQS; Squalene synthase; squalene synthetase; SS | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 2222 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.55 mg/mL | |
| 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 | |
| P37268 | |
| FDFT1 | |
| Recombinant protein encompassing a sequence within the center region of human FDFT1. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction